Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 976

1.

Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.

Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MA.

Cancer Res. 2000 Feb 1;60(3):610-7.

PMID:
10676644
[PubMed - indexed for MEDLINE]
Free Article
2.

Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells.

Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA.

Blood. 1997 Jul 1;90(1):182-93.

PMID:
9207452
[PubMed - indexed for MEDLINE]
Free Article
3.

Telomerase activity in myelodysplastic syndromes.

Gürkan E, Tanriverdi K, Başlamişli F.

Leuk Res. 2005 Oct;29(10):1131-9. Epub 2005 Apr 7.

PMID:
16111531
[PubMed - indexed for MEDLINE]
4.

Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells.

Goselink HM, Williams DE, Fibbe WE, Wessels HW, Beverstock GC, Willemze R, Falkenburg JH.

Blood. 1992 Aug 1;80(3):750-7.

PMID:
1638026
[PubMed - indexed for MEDLINE]
Free Article
5.

Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.

Bhatia R, Munthe HA, Williams AD, Zhang F, Forman SJ, Slovak ML.

Exp Hematol. 2000 Dec;28(12):1401-12.

PMID:
11146162
[PubMed - indexed for MEDLINE]
6.
7.

Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.

Van den Berg D, Wessman M, Murray L, Tong J, Chen B, Chen S, Simonetti D, King J, Yamasaki G, DiGiusto R, Gearing D, Reading C.

Blood. 1996 May 15;87(10):4348-57.

PMID:
8639795
[PubMed - indexed for MEDLINE]
Free Article
8.

Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry.

Brümmendorf TH, Holyoake TL, Rufer N, Barnett MJ, Schulzer M, Eaves CJ, Eaves AC, Lansdorp PM.

Blood. 2000 Mar 15;95(6):1883-90.

PMID:
10706851
[PubMed - indexed for MEDLINE]
Free Article
9.

5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells.

Jazwiec B, Mahon FX, Pigneux A, Pigeonnier V, Reiffers J.

Exp Hematol. 1995 Dec;23(14):1509-14.

PMID:
8542939
[PubMed - indexed for MEDLINE]
10.

Stem cell factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34(+) cells.

Moore S, Haylock DN, Lévesque JP, McDiarmid LA, Samels LM, To LB, Simmons PJ, Hughes TP.

Blood. 1998 Oct 1;92(7):2461-70.

PMID:
9746786
[PubMed - indexed for MEDLINE]
Free Article
11.
12.

Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.

Stilz R, Grünebach F, Bader P, Vogel W, Kanz L, Brugger W, Scheding S.

J Hematother Stem Cell Res. 2001 Dec;10(6):777-85.

PMID:
11798504
[PubMed - indexed for MEDLINE]
13.

Deficient proliferation and expansion in vitro of two bone marrow cell populations from patients with acute myeloid leukemia in response to hematopoietic cytokines.

Montesinos JJ, Sánchez-Valle E, Flores-Figueroa E, Martínez-Jaramillo G, Flores-Guzmán P, Miranda-Peralta E, Gutiérrez-Romero M, Mayani H.

Leuk Lymphoma. 2006 Jul;47(7):1379-86.

PMID:
16923572
[PubMed - indexed for MEDLINE]
14.

BCR/ABL- CD34(+)HLA-DR- progenitor cells in early chronic phase, but not in more advanced phases, of chronic myelogenous leukemia are polyclonal.

Delforge M, Boogaerts MA, McGlave PB, Verfaillie CM.

Blood. 1999 Jan 1;93(1):284-92.

PMID:
9864172
[PubMed - indexed for MEDLINE]
Free Article
15.

Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.

Einat M, Lishner M, Amiel A, Nagler A, Yarkorli S, Rudi A, Kashman Y, Markel D, Fabian I.

Exp Hematol. 1995 Dec;23(14):1439-44.

PMID:
8542929
[PubMed - indexed for MEDLINE]
16.

Perturbation in the ability of bone marrow stroma from patients with acute myeloid leukemia but not chronic myeloid leukemia to support normal early hematopoietic progenitor cells.

Sparrow RL, O'Flaherty E, Blanksby TM, Szer J, Van Der Weyden MB.

Leuk Res. 1997 Jan;21(1):29-36.

PMID:
9029183
[PubMed - indexed for MEDLINE]
17.

In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.

Kobari L, Pflumio F, Giarratana M, Li X, Titeux M, Izac B, Leteurtre F, Coulombel L, Douay L.

Exp Hematol. 2000 Dec;28(12):1470-80.

PMID:
11146169
[PubMed - indexed for MEDLINE]
18.

Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia.

Drummond M, Lennard A, Brûmmendorf T, Holyoake T.

Leuk Lymphoma. 2004 Sep;45(9):1775-81.

PMID:
15223635
[PubMed - indexed for MEDLINE]
19.

Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.

Leemhuis T, Leibowitz D, Cox G, Silver R, Srour EF, Tricot G, Hoffman R.

Blood. 1993 Feb 1;81(3):801-7.

PMID:
7679000
[PubMed - indexed for MEDLINE]
Free Article
20.

Transforming growth factor beta3 inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis.

Fogli M, Carlo-Stella C, Curti A, Ratta M, Tazzari PL, Ragazzi E, Colla S, Santucci AM, Tura S, Lemoli RM.

Exp Hematol. 2000 Jul;28(7):775-83.

PMID:
10907639
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk